Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®*, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
At Bicker Elektronik GmbH in Donauwoerth/Germany, the three models of the new Delta GPS series are already available fro…
Premier American Uranium Inc. (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR - https://www.commodity-t…
Mouser Electronics, Inc., the New Product Introduction (NPI) leader™ empowering innovation, announces a new eBook in col…
Sibanye-Stillwater (JSE: SSW and NYSE: SBSW - https://www.commodity-tv.com/...) advises stakeholders that it will enter…
At Techtextil in Frankfurt am Main, Germany, the ITA Group will be presenting its entire range of research on sustainabi…
INFODAS GmbH, a leading company in the field of cybersecurity solutions, has been awarded the type approval certificate…
The Commonwealth of Australia has today signed the production contract for 123 Boxer Heavy Weapon Carrier vehicles with…
VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoceptor t…
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating sever…